BioCorRx Inc. (BICX): Cost of Revenue

Annual figures by period end, from SEC filings.

$1.7K
Year ended 2024-12-31
-34.3%
3-year compound annual growth
-54.1%
5-year compound annual growth
-38.7%
10-year compound annual growth
$402.5K2010-12-31: $156.2K2011-12-31: $400.4K2012-12-31: $402.5K2013-12-31: $160.2K2014-12-31: $221.0K2015-12-31: $152.0K2016-12-31: $175.4K2017-12-31: $323.6K2018-12-31: $171.0K2019-12-31: $81.7K2020-12-31: $95.9K2021-12-31: $5.9K2022-12-31: $15.3K2023-12-31: $36.0K2024-12-31: $1.7K$1.7K
2010-12-31 Cost of Revenue (USD) 2024-12-31
Period endedCost of RevenueChange YoYSource filing
2024-12-31$1.7K-95.4%2025-03-31, From 2024-01-01
2023-12-31$36.0K+135.5%2025-03-31, From 2023-01-01
2022-12-31$15.3K+159.8%2024-04-01, From 2022-01-01
2021-12-31$5.9K-93.9%2022-03-31, From 2021-01-01
2020-12-31$95.9K+17.5%2022-03-31, From 2020-01-01
2019-12-31$81.7K-52.2%2021-03-31, From 2019-01-01
2018-12-31$171.0K-47.2%2020-03-30, From 2018-01-01
2017-12-31$323.6K+84.5%2019-04-16, From 2017-01-01
2016-12-31$175.4K+15.4%2018-04-05, From 2016-01-01
2015-12-31$152.0K-31.2%2017-04-13, From 2015-01-01
2014-12-31$221.0K+37.9%2016-04-14, From 2014-01-01
2013-12-31$160.2K-60.2%2015-03-31, From 2013-01-01
2012-12-31$402.5K+0.5%2014-04-14, From 2012-01-01
2011-12-31$400.4K+156.3%2013-04-15, From 2011-01-01
2010-12-31$156.2Kn/a2012-05-18, From 2010-01-01